There are 702 resources available
334P - Prognostic factors for early recurrence after resection of pancreatic cancer: A systematic review and meta-analysis
Presenter: Carl Leonhardt
Session: Poster Display session
335P - Management, outcome and prognostic factors of metastatic pancreatic cancer
Presenter: Sarra Maatallah
Session: Poster Display session
336P - Modified technique of duct to mucosa pancreaticojejunal anastomosis in Whipple`s pancreatoduodenectomy outcomes of a novel technique
Presenter: varadharajan vijayakumar
Session: Poster Display session
337P - Real-life second-line therapies outcome in metastatic pancreatic cancer (mPDAC) patients previously treated with gemcitabine plus nab-paclitaxel (Gem-Nab): An Italian multicenter study
Presenter: Sara Lonardi
Session: Poster Display session
338P - Heads or tails? In-depth analysis of pancreatic cancer outcomes according to tumour location
Presenter: Alexandra Fernandes
Session: Poster Display session
340P - Molecular profiling in pancreatic cancers: Therapeutic and prognostic impact
Presenter: Anthony Tarabay
Session: Poster Display session
341P - Clinical experience with S-1 or FOLFOX as third-line treatment in patients with metastatic pancreatic cancer who received first-line gemcitabine + nab-paclitaxel and second-line nanoliposomal-irinotecan + 5-FU/leucovorin
Presenter: Tomomi Sanomachi
Session: Poster Display session
342P - Is there still a role for consolidation radiotherapy in locally advanced pancreatic cancer?
Presenter: Loic Ah-thiane
Session: Poster Display session
343P - Current biomarker and treatment landscape in pancreatic ductal adenocarcinoma (PDAC): A retrospective cohort study
Presenter: Mark Lewis
Session: Poster Display session
344P - Survival predictors in pancreatic cancer patients on liposomal irinotecan plus fluorouracil/leucovorin: A multicenter observational study
Presenter: Jiyoung Keum
Session: Poster Display session